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Summary 
Memory or antigen-experienced CD4 T cells differ from 
naive CD4 T cells both phenotypically by cell surface 
marker expression, and functionally by their dissimilar 
pattern of cytokine secretion and activation require- 
ments through their T cell receptor (TCR). We show 
here that activation of memory CD4 T cells (CD45RB”’ 
subset), but not naive CD4 T cells (CD45RBhi subset), 
is inhibited by MHC class II molecules on antigen-pre- 
senting cells and by CD4 ligation. We propose that the 
selective negative signal in memory cells is a direct 
result of the differences in signaling via CD4 and CD3, 
exemplified in the disparate pattern of tyrosine-phos- 
phorylated proteins visible after activation of the two 
subsets. In vivo, this inhibitory signal may serve to 
prevent irrelevant interactions between memory CD4 
T cells and bystander MHC class II+ cells, and may 
also be responsible for the defective functioning of 
memory CD4 T cells in AIDS. 
Introduction 
A memory or recall immune response protects against 
reexposure to a particular pathogen and differs from a 
primary response in rapidity, magnitude, and duration. 
Memory is manifested by the generation of antigen- 
specific T cells that differ from naive T cells: quantitatively, 
by their increased precursor frequency due to previous 
expansion during the primary response, and qualitatively, 
by their production of a diverse array of cytokines and by 
their longevity (Mackay, 1991; Gray, 1993; Bradley et al., 
1993). Memory CD4 T cells can be phenotypically distin- 
guished from naive CD4 T cells based on the expression 
of various cell surface markers, including distinct isoforms 
of the CD45 glycoprotein (Smith et al., 1966; Sanders et 
al., 1966; Salmon et al., 1969; Lee et al., 1990; Dianzani 
et al., 1990), the adhesion molecule CD44, or Pgp-1 (San- 
ders et al. 1988; Budd et al., 1987), and the homing recep- 
tor MEL-14 (Lee and Vitetta, 1991; Bradley et al., 1992). 
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Isolation of memory and naive CD4 T cells based on these 
surface markers has enabled characterization of func- 
tional differences between these two CD4 T cell subsets. 
Studies of CD45defined subsets in human (Byrne et 
al., 1988; Horgan et al., 1990; Sanders et al. 1989) and 
in mouse (Luqman and Bottomly, 1992) have revealed that 
memory CD4 T cells differ from naive CD4 T cells in their 
activation requirements for stimulation through the T cell 
receptor (TCR)-CD3 complex. As we have previously re- 
ported (Luqman and Bottomly, 1992), mouse memory CD4 
T cells (CD45RB’O subset) proliferate in response to anti- 
CD3 immobilized on plastic surfaces, while naive cells 
(CD45RBhi subset) do not. However, naive CD4 T cells 
can be induced to proliferate if anti-CD3 is presented by Fc 
receptor (FcR)-bearing antigen-presenting cells (APCs) 
from normal spleen, suggesting that naive cells have a 
greater requirement for costimulatory signals than mem- 
ory cells. 
During the course of these studies, we made the para- 
doxical observation that although naive CD4 T cells were 
activated in the presence of anti-CD3 and T-depleted 
splenic APC, memory CD4 T cells failed to respond to this 
stimulus. The fact that memory CD4 T cells could respond 
to anti-CD3 immobilized on plastic or cross-linked by FcR- 
bearing fibroblasts suggested that splenic APCs were de- 
livering an inhibitory signal selectively to the memory CD4 
T cells. As it is well known that CD4 cross-linking can 
inhibit CD4 T cell responses to anti-CD3 and other mito- 
gens (Bank and Chess, 1985; Tite et al., 1986; Newell et 
al., 1990; Rosoff et al., 1987; Wassmer et al., 1985; Jane- 
way et al., 1988), we have examined the role of the CD4 
ligand, major histocompatibility complex (MHC) class II, 
and of the CD4 molecule itself in this inhibitory effect. 
We find that inhibition of memory CD4 T cell activation 
by spleen APCs plus anti-CD3 requires expression of MHC 
class II molecules on the cell presenting anti-CD3. Thus, 
anti-CD3 presented by FcR+/MHC class II positive (II+) 
APC prevents activation of memory CD4 T cells, whereas 
anti-CD3 presented by FcR+ APC that lack MHC class II 
molecules (Ilo) stimulates memory CD4 T cells to prolifer- 
ate and produce effector cytokines such as interferon? 
(IFNy) and interleukin-4 (IL-4). Moreover, ligation of CD4 
on memory CD4 T cells reproduces the inhibitory effect 
of MHC class II+ APC but does not inhibit naive CD4 T cell 
activation, further demonstrating that signals that impede 
memory CD4 T cell activation can be delivered through 
the CD4 molecule. A molecular basis for this differential 
activation is manifested by the dissimilar pattern of tyro- 
sine-phosphorylated proteins that appear after CD4 or 
CD3 cross-linking in the two subsets, suggesting that CD4 
and CD3 are coupled to different signaling pathways in 
the two cell types. 
We propose that the inhibitory signal delivered selec- 
tively by CD4 on CD45RB’” CD4 T cells may serve to pre- 
vent these memory cells from bystander activation by 
MHC class II-bearing cells in the absence of a TCR- 
mediated signal. These results also suggest that activation 
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Table 1. Summary of Differential Activation Requirements of 
CD45RB” and CD45RB”’ Cells 
Stimulus’ CD45RB” CD45RB”’ 
Immobilized anti-CD3 -I-+ 
Soluble anti-CD3 - 
Soluble anti-CD3 plus CHOlFcrRll cell@ +++ - 
Soluble anti-CD3 plus T-depleted - +++ 
splenocyteti 
a All results summarized from Luqman and Bottomly, 1992, unless 
otherwise indicated. 
b Cells are described (Luqman and Bottomly, 1992). 
c Results presented here. 
of memory CD4 T cells may be stringently controlled in 
ways that differ from the regulation of naive CD4 T cell 
activation. 
Results 
Mouse CD4 T cells can be separated on the basis of 
CD45RB isoform expression using the 16A monoclonal 
antibody (MAb) to exon &encoded determinants of CD45. 
CD4 T cells separated in this way have been shown to 
represent memory (CD45RB’“) and naive (CD45RBhi) CD4 
T cell subsets (Lee et al., 1990; Dianzani et al., 1990; 
Bottomly et al., 1969). As previously demonstrated (Luq- 
man and Bottomly, 1992) CD45RB” CD4 T cells compris- 
ing the memory subset, and CD45RBh’ CD4 T cells, com- 
prising the naive subset, exhibited disparate reactivities 
to anti-CD3 presented in different contexts. These data are 
summarized in Table 1. In response to plastic-immobilized 
antiCD3, known to be a potent stimulus for T cells (Samel- 
son et al., 1967), CD45RB’O CD4 T cells proliferated well, 
whereas CD45RBhi CD4 T cells failed to proliferate. This 
differential activation was duplicated in response to solu- 
ble anti-CD3 presented by FcR-bearing CHO fibroblast 
transfectants. The only stimulus that induced proliferation 
of CD45RBhi CD4 T cells was soluble anti-CD3 presented 
by T-depleted splenocytes as APC. Such “professional” 
APC cross-link anti-CD3 bound to TCRlCD3 on T cells via 
surface FcR, and also provide costimulatory activity (Liu 
and Janeway, 1992). Thus, memory CD4 T cells defined 
by low expression of CD45RB could be activated solely 
by cross-linking TCWCD3, whereas naive CD4 T cells, 
defined by high expression of CD45RB, required both 
TCRICD3 cross-linking and an additional stimulus pro- 
vided by a professional APC. 
CD45RW CD4 T Cells Respond to Immobilized 
Anti-CD3 but Fail to Respond to Anti-CD3 
plus Splenic APC by Proliferation 
and Cytokine Synthesis 
Further analysis of naive and memory CD4 Tcell activation 
yielded the unexpected finding that memory CD4 T cells 
did not respond to anti-CD3 presented by T-depleted 
spleen cells as APC. In these experiments, naive and 
memory CD4 T cells were prepared from resting CD4 T 
cells and separated using antiCD45RB antibodies into 
CD45RB hi 
t 
10’ 102 103 
Fluorescence Intensity 
Figure 1. CD45RB Surface Expression of Splenic CD4+ TCells Before 
Sorting and CD45RB” and CD45RB”’ Subsets After Magnetic Bead 
Sorting on the MACS 
CDCcells werestained withC363.16A-biotin, followed bystreptavidin 
magnetic beads and fluorescein isothiocyanate-avidin, separated on 
the MACS, and analyzed on the FACScan. 
CD45RBhi (naive) and CD45RB”‘(memory cells) (Figure 1). 
The CD45RB’O subset also expressed low levels of MEL-l 4 
and high levels of Pgp-1 (data not shown), consistent with 
a memory cell phenotype. These cells were then assayed 
for their ability to respond to anti-CD3 presented by 
T-depleted splenocytes (Figure 2A). CD45RBhi CD4T cells 
proliferated vigorously to anti-CD3 presented by APC, con- 
sistent with previous findings (Luqman and Bottomly, 
1992) whereas CD45RB’O CD4 T cells failed to proliferate 
in response to this stimulus. CD45RB’O CD4 T cells prolifer- 
ated well in response to immobilized anti-CD3 as well as 
anti-CD3 presented by FcR+ CHO cells (Luqman and Bot- 
tomly, 1992; data not shown), demonstrating that these 
cells respond to TCWCDB cross-linking. The selective in- 
hibition of CD45RB’” CD4 T cells by anti-CD3 and splenic 
APC was demonstrated at a broad range of antibody con- 
centrations and at different timepoints (data not shown). 
To determine whether other features of memory CD4 T 
cell responses, such as effector cytokine release, were 
also inhibited in the presence of spleen APC, production 
of IL4 and IFNy by anti-CD3-activated CD45RB” CD4 T 
cells was measured. As demonstrated in Figure 28, 
CD45RB’” CD4 T cells produced IL4 and IFNy in response 
to activation by immobilized anti-CDS, but produced very 
low levels of these cytokines in response to anti-CD3 and 
T-depleted splenocytes. Thus, cross-linking of TCRICD3 
on the surface of CD45RB” CD4 T cells by FcR+ splenic 
APC inhibits both proliferation and effector cytokine release. 
This inhibition is selective for the memory (CD45RBq sub- 
set and does not affect the response of naive CD4 T cells 
expressing high levels of CD45RB. 
These results indicate that T-depleted spleen cells de- 
liver an inhibitory signal that blocks T cell proliferation and 
cytokine production by CD45RBb CD4 T cells activated 
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Figure 2. The CD45RW Memory Subset Fails to Respond to Stimula- 
tion by Anti-CD3 plus APC 
(A) Proliferative response of CD45RB” versus CD45RB”’ cells to anti- 
CD3(29B) plus T-depleted splanocytes compared with proliferation of 
CD45RBs calls to plastic immobilized anti-CD3 Proliferation was mea- 
sured after 4 days as described in Experimental Procedures. 
(B) Cytokina profile of CD45RB” cells following treatment with immobi- 
lized anti-CD3 or anti-CD3 and APC. IL-4 and IFNT were measured 
by bioassay (see Experimental Procedures) with 1 U defined as half- 
maximal response. 
by FcR cross-lin ked antiCD3. The experiments that follow 
seek to define the nature of the molecules that mediate 
the negative effects on CD45RB’” CD4 T cells. 
CD45RB” CD4 T Cells Are Signaled by Anti-CD3 
plus Splenic APC as Shown by Induction 
of Proliferation to Exogenous IL-2 
Two possible explanations can account for the failure of 
CD45RB” CD4 T cells to respond to anti-CD3 presented 
by T-depleted spleen cells; either this form of presentation 
kills the responding T cells or it fails to signal them. Al- 
though examination of CD45RB” CD4 T cells by trypan 
blue staining 48 hr after incubation with anti-CD3 and APC 
revealed no overt cell death (data not shown), both of these 
possibilities can be ruled out by adding exogenous IL-2 
to the cultures. As shown in Figure 3, stimulation with 
anti-CD3 and T-depleted spleen cells induces CD45RBio 
CD4 T cells to proliferate in response to IL-2. IL-2 also 
enhances the proliferative response of naive CD45RBhi 
CD4Tcells to anti-CD3 and T-depleted spleen cells. These 
results indicate that memory CD4 T cells remain viable 
and are signaled in the presence of anti-CD3 and splenic 
APC, but do not proliferate unless provided with exoge- 
nous IL-2. However, the CD45RB” cells do not appear 
anergic, because following treatment with anti-CD3 and 
splenic APC, they are still able to respond to immobilized 
anti-CD3 (data not shown). 
+IL-2 +IL-2 
CD45RBio CD45RBhi 
Figure 3. The Failure of Memory CD4 T Calls to Respond to Anti-CD3 
and Class II+ APC Can Be Overcome by Providing IL-2 
Proliferative responses of CD45RB” and CD45RB”’ CD4 T calls to 10 
uglml anti-CD3 and MHC class II+ APC f 50 U/ml mouse recombinant 
IL-2. Background proliferation with IL-2 alone was <2000 cpm. 
MHC Class II Expression by FcR+ Cells Inhibits 
Prollferatlon of and Effector Cytokine 
Secretion by Memory but not Naive 
CD4 T Cells Induced by Anti-CD3 
Because memory CD4 cells could be activated by immobi- 
lized anti-CD3 or anti-CD3 presented by FcR-bearing fibro- 
blasts but not by FcR-bearing T-depleted splenic APC, 
it seemed likely that splenic APC surface structures not 
expressed by fibroblasts were inhibiting memory CD4 T 
cell activation. It has been shown previously that cross- 
linking of CD4 can deliver an inhibitory signal to CD4 T 
cells activated by anti-receptor antibodies or mitogenic 
lectins (Bank and Chess, 1985; Tite et al., 1986; Wassmer 
et al., 1985; Haque et al. 1987). The natural ligand of CD4 
is MHC class II, which is known to bind and cross-link 
CD4 (Doyle and Strominger, 1987). Since FcR+ cells in 
T-depleted spleen are MHC class II+ and inhibit CD45RB’O 
CD4 T cell responses to antiCD3, whereas MHC class II0 
FcR+ fibroblasts support such responses, we asked 
whether MHC class II is the crucial molecule required for 
inhibition of memory CD45RBb CD4 T cell responses to 
antiCD3. 
To address this question, the full-length cDNA encoding 
murine Fc-rRllbP (Ravetch et al., 1986) was transfected 
into MHC class II0 and into I-Ad-expressing MHC class II+ 
fibroblasts (K&rig et al., 1992). The resultant transfectants, 
L/FcR+/II” and L/FcR+/II+, were paraformaldehyde fixed to 
prevent fibroblast proliferation and tested for their ability 
to activate anti-CD3-treated CD45RB’” CD4 T cells. As 
shown in Figure 4A, both L/FcR+III”and UFcR+III+ express 
comparable amounts of FcR, whereas only UFcR+/II+ ex- 
presses I-Ad. When anti-CD3 was presented to CD45RB’O 
CD4T cells by thesetwo transfectants, only the MHC class 
II-(UFcR+/IlO) fibroblasts induced proliferation (Figure4B). 
By contrast, MHC class II’ fibroblasts (UFcR+/ll+) failed to 
induce proliferation even at high anti-CD3 concentrations. 
Thus, the presence of MHC class II on a nonprofessional 
APC inhibits memory CD4 T cell activation. 
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Figure 4. Memory CD4 T Cell Response to FcR’ Fibroblasts Is Regu- 
lated by MHC Class II 
(A) FACS profile showing FcyR and MHC class II surface expression 
by L cell transfectants as assessed by staining with MAbs 2.462 and 
212.A1, respectively. 
(8) Proliferative response of CD45RB” cells to soluble anti-CD3 pre- 
sented by UFcR+/IIO, UFcR+/ll+, and L/FcRVII+ transfectants. 
As our original data describing memory CD4 T cell unre- 
sponsiveness involved presentation of anti-CD3 by splenic 
APC and not by fibroblasts, the ability of T-depleted sple- 
nocytes obtained from mice defective for MHC class II 
expression to present anti-CD3 was also analyzed. As 
seen in Figure 5A, anti-CD3 presented by either MHC class 
II+ or MHC class II0 splenic APC strongly stimulated prolif- 
eration of naive CD4 T cells, although proliferative re- 
sponses were somewhat stronger when MHC class II0 
splenic APC were used. By contrast, anti-CD3 presented 
by MHC class II+ splenic APC did not induce proliferation 
of CD45RB’O CD4 T cells, whereas anti-CD3 presented by 
MHC class II0 T-depleted spleen cells induced excellent 
proliferative responses. Moreover, production of the ef- 
fector cytokines IL-4 and IFNy by memory CD45RB’” CD4 
T cells occurred only when anti-CD3 was presented by 
MHC class II0 cells and not when it was presented by MHC 
class II+ cells (Figure 58). 
Both MHC class II0 and MHC class II’ APC express 
equivalent levels of FcrRII, as assessed by staining with 
MAb 2.4G2 and anti-CD3-treated memory cells formed 
comparable numbers of rosettes with MHC class II+ and 
MHC class II0 APC (data not shown), eliminating the possi- 
bility that MHC class II0 APCs are capable of more exten- 
sive cross-linking via their Fc receptors. Moreover, prolifer- 
ation induced by the MHC class II0 APCs themselves can 
be ruled out because no proliferation was observed when 
CD45RB’” or CD45RBh’ cells were incubated with MHC 
class II0 APC alone (Figure 5, legend), and antiCD3- 
- . . . . . _ 
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Figure 5. Memory CD4 T Cell Responsiveness Is Controlled by Ex- 
pression of MHC Class II on the Splenic APC 
(A) Proliferative response of CD45RBbCD4T cells to 5 pg./ml anti-CD3 
plus class II+ APC versus class II- APC (Ii”) isolated from MHC class 
II knockout mice. The following cpm were obtained when no anti-CD3 
was added: CD45RBr” plus II’APC, 360; CD45RB” plus IPAPC, 343; 
CD45RB”’ plus II’APC, 143; CD45RB”’ plus IPAPC, 196. 
(6) Cytokine production by CD45RB” cells in response to soluble anti- 
CD3 plus class II+ APC or class IF APC. 
induced proliferation by MHC class IIOAPC wascompletely 
inhibited by the anti-FVRII MAb, 2.4G2 (see Figure 7). 
Thus, the presence of MHC class II molecules on an 
FcyR-bearing cell inhibits activation of CD45RB” memory 
CD4Tcellsstimulated bysolubleanti-CD3while not signif- 
icantly affecting identical stimulation of naive CD45RBhi 
CD4 T cell responses. 
Inhibitory Effects of MHC Class II+ APCs 
Are Not Observed In Trans 
Given the ability of CD45RB” cells to respond to anti-CD3 
presented by MHC class II0 APC, but not to antibody pre- 
sented by MHC class II+ APC, we asked whether contact 
with MHC class II+ APC distinct from anti-CD3 cross- 
linking was sufficient to shut off memory cell activation. 
Thus, if activating and inhibitory signals are uncoupled, 
and therefore not delivered by the same accessory cell, 
can CD45RB’” cells then be activated? 
To address this question, we used two approaches. 
First, we treated CD45RB” cells with anti-CD3 presented 
by FcR+/MHC class II0 splenocytes plus either FcRO/MHC 
class II+ fibroblasts (L/FcR”/II+) to determine whether this 
two-cell combination would exhibit the same inhibitory ef- 
fects as the FcR+III+ presenting cells (see Figure 48; Fig- 
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Figure 6. Inhibition of CD45RW Activation by MHC Class II Cannot 
Occur In Trans 
(A) CD45RB” cells (50,000 per well) were incubated with 10 uglml of 
anti-CD3 plus MHC class II0 T-depleted splenocytes (75,000 per well) 
plus increasing amounts of paraformaldehyde-fixed L cells or L cells 
expressing MHC class II molecules (WI+) and proliferation was mea- 
sured after 4 days. 
(6) CD45RW cells (25,000 per well) were incubated with anti-CD3 in 
immobilized or soluble form f MHC class II+ T-depleted splenocytes 
(75,000 per well) and proliferation was assessed after 4 days. 
ure 6A). As shown in Figure 6A, presentation of anti-CD3 
by MHC class II0 splenocytes plus L/FcR”/II+ stimulated 
CD45RB’” cells to proliferate to the same extent as with 
UFcR+III” plus L cells added as controls, indicating that 
the addition of MHC class II+ cells in trans was not suffi- 
cient to inhibit memory cell proliferation to an activating 
stimulus. 
To determine whether the same mechanism was opera- 
tive with MHC class II+ splenic APC, we used a second 
approach and asked whether contact with splenic MHC 
class II+ APC could inhibit CD45RBr” activation by immobi- 
lized anti-CD3. As shown in Figure 6B, immobilized anti- 
CD3 alone stimulated CD45RBr0 proliferation, whereas im- 
mobilized anti-CD3 plus splenic APC augmented this 
proliferation P-fold. Again, soluble anti-CD3 plus the same 
ratio of MHC class II+ APC failed to activate CD45RB’O 
cells. The activation induced by immobilized anti-CD3 plus 
APC was not due to FcR-mediated cross-linking of anti- 
CD3 bound to T cells, because this proliferation was not 
inhibited by an anti-FcR antibody 2.462, at a concentration 
that completely blocked CD45RBhi cell activation by solu- 
ble anti-CD3 plus APC (data not shown). Thus, splenic 
APC appear to augment CD45RB” activation when pro- 
vided in trans to TCR cross-linking and inhibit activation 
when provided in cis to TCR cross-linking. 
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Figure 7. Cross-Linking CD4 inhibits CD45RB” CD4 T Cell Prolifera- 
tion Induced by MHC Class II0 APC but Does Not Block CD45RB”’ 
Proliferation to MHC Class II+ or MHC Class II” APC 
(A) CD45RB” CD4 T cells were treated with 10 @ml anti-CD3 and 
T-depleted splenocytes from BALB/c (II+ APC) or MHC class II knock- 
out mice (II0 APC) f 10 pa/ml of an isotype-matched control antibody 
(TIB 210, anti-CDB), anti-CD4(GK1.5), or anti-FcRII (2.4(32), and prolif- 
eration was assessed as described above. 
(B) CD45RB”’ CD4 T cells in the same experiment were treated as in 
(A) f TIB 210 control antibody or GK1.5. Addition of as much as 20 
&ml of GK1.5 did not inhibit CD45RBh’CD4T proliferation to II’ APC 
or II0 APC (data not shown). 
Cross-Linking CD4 Inhibits Proliferation of Memory 
but Not Naive CD4 T Cells Induced by Anti-CD3 
The difference in activation of memory CD4 T cells by 
anti-CD3 seen with MHC class II+ versus MHC class II0 
APC suggested that a negative signal was being trans- 
duced to memory CD4 T cells via interaction with MHC 
class II, whose only known receptor on these cells is CD4. 
Numerous studies have shown that proliferation and ef- 
fector function of T cells can be inhibited by cross-linking 
CD4. However, the effect of CD4 cross-linking on the acti- 
vation of normal naive and memory CD4 T cells has never 
been examined. To establish that a selective negative sig- 
nal could be delivered through CD4 on the surface of a 
memory CD4 T cell, but not through CD4 on naive CD4 
T cells, we sought to mimic the inhibitory effect of MHC 
class II+ APC by cross-linking CD4 with anti-CD4 MAbs 
in the presence of MHC class II0 APC. As shown in Figure 
7A, proliferation of CD45RB’” CD4Tcells to anti-CD3 in the 
presence of MHC class II0 APC was inhibited by addition of 
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Figure 8. Comparison of Tyrosine-Phosphorylated Proteins in Rest- 
ing, AntiCD3- and Anti-CDQTreated Whole CD4’ Cells and CD4’ 
CD45RB lsoform Subsets 
(A) Kinetics of appearance of tyrosinephosphorylated products in 
whole CD4+ cells. Cells (1.6 x I@ equivalents per lane) were treated 
at 37OC for the times indicated with either anti-CD3 ((X63.298 plus 
goat anti-rat IgG), or anti-CD4 (IgM RL172.5). Cell lysates were re- 
solved on 5%-15% gradient SDS gels, transferred to nitrocellulose, 
resultant blots were hybridized with anti-phosphotyrosine antibody, 
and bands were revealed by chemiluminescence. Lane 1, untreated; 
lane 2, anti-CD3 for 30 s; lane 3, anti-CD3 for 2 min; lane 4, anti-CD3 
for 5 min; lane 5. anti-CD3 for 10 min; lane 6, anti-CD3 for 30 min; 
lane 7, anti-CD4 for 30 s; lane 8, anti-CD4 for 2 min; lane 9, anti-CD4 
for 5 min. 
(6) Phospho-tyrosine blots of lysates from CD45RB” and CD45RB”’ 
cells. Each lane represents 1.5 x 1 Oe cell equivalents. Lanes 1 and 
4, antiCD3, 10 min; lanes 2 and 5, anti-CD3 for 2 min; lanes 3 and 6, 
anti-CD3 for 30 s; lanes 7 and 9, anti-CD4 for 2 min; lanes 8 and 
10, untreated controls. Molecular mass standards are designated (in 
kilodaltons): 116, 97, 66, 55, 36.5, 31, 21.5. 
the anti-CD4 MAb GK1.5, but not with an isotype-matched 
control antibody. GKl .Binduced inhibition was apparent 
at low doses of antibody (data not shown). By contrast, 
addition of GK1.5 failed to inhibit the proliferative response 
of CD45RBhi CD4 T cells to anti-CD3 together with either 
MHC class 11” or MHC class II+ APC (Figure 78). These 
data are consistent with the results presented above, 
showing that only CD45RW’ CD4 T cells are inhibited by 
contact with MHC class II+ cells. Thus, our data demon- 
strate that MHC class II on APC can deliver a negative 
signal to memory but not naive CD4 T cells, and strongly 
suggest that this negative signal is delivered via CD4. 
Memory and Naive Cells Display Different Patterns 
of Tyrosine Phosphorylation 
The results presented above strongly suggest that signal- 
ing through both the TCWCD3 complex and through CD4 
in memory CD4 T cells differs from that in naive CD4 T 
cells. To determine whether differential activation via CD3 
and differential inhibition via CD4 reflect distinct intracellu- 
lar signaling in the two subsets, we examined the appear- 
ance of tyrosine-phosphorylated substrates in both whole 
CD4 T cells and CD45RB subsets immediately following 
CD3 or CD4 cross-linking. As shown in Figure 8A, resting 
whole CD4 cells display few tyrosine-phosphorylated 
bands (lane 1); following CD3 cross-linking for increasing 
times, major bands of 21 kDa, 42 kDa, 70-80 kDa, and 
97-116 kDa appear (lanes 2-6). Following CD4 cross- 
linking by immunoglobulin M (IgM) anti-CD4, novel bands 
of 34 and 36 kDa appear and the 42 kDa and higher molec- 
ular mass bands seen with anti-CD3 stimulation lose their 
prominence (Figure 8, lanes 7-9). 
A similar timecourse of stimulation of CD45RB’O versus 
CD45RBhi cells is compared in Figure 88. In general, the 
patterns of tyrosine-phosphorylated substrates observed 
in resting, anti-CD3 cross-linked, and anti-CD4 cross- 
linked CD45RB subsets differs; fewer species of tyrosine- 
phosphorylated proteins appear in stimulated memory 
cells when compared with naive cells or whole CD4 cells. 
Nonactivated CD45RW and CD45RBhi cells express few 
tyrosine-phosphotylated substrates, with the exception of 
a 40 kDa band that is constitutively present in CD45RB’O 
cells (Figure 8, lane 10) but not in CD45RBhi cells (lane 
8). After cross-linking CD4, the two bands of 34-36 kDa 
seen in whole CD4 cells are more strongly induced in 
CD45RBhi cells (Figure 8, lane 7) than in CD45RB” CD4 
Tcells, which also exhibit a marked increase in phosphory- 
lation of the 40 kDa band after CD4 cross-linking (lane 9). 
Thus, cross-linking CD4 on naive and memory CD4 T cells 
induces different patterns of tyrosine-phosphorylated sub- 
strates consistent with the distinct physiologic effects of 
CD4 ligation in these two populatons. 
Cross-linking CD3 also produces different functional 
outcomes in naive and memory CD4 T cells and likewise 
generates strikingly distinct patterns of tyrosine-phosphor- 
ylated substrates. In response to anti-CD3 stimulation, 
strongly tyrosine-phosphorylated proteins of 42 kDa, 70- 
80 kDa, and three high molecular mass bands between 
96-120 kDa appear in CD45RB”’ cells (Figure 8B, lanes 
l-3), and likewise in whole CD4 cells (Figure 8A, lane 2) 
but are notably absent in CD45RB” cells (Figure 8B, lanes 
4-6). The constitutive 40 kDa band in CD45RB’O cells ap- 
pears more strongly phosphorylated as a result of CD3 
cross-linking (Figure 6B, lanes 4-6), and migrates faster 
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than the 42 kDa band observed in anti-CD&treated 
CD45RB”’ cells. Only one high molecular mass band ap- 
pears in anti-CD3etimulated CD45RB’0cells, correspond- 
ing to the lowest of the three high M, bands seen in stimu- 
lated CD45RBhi cells. 
These data indicate that proximal signaling events trans- 
duced both through CD3 and CD4, namely the phosphory- 
lation on tyrosines of various cytoplasmic substrates, dif- 
fers strikingly between naive and memory cells. 
Discussion 
This study demonstrates both functional and biochemical 
differences in the activation of naive and memory CD4 T 
cells freshly isolated from normal donor mice. These two 
CD4 T cell subpopulations were defined by differential 
expression of the CD45RB isoform or isoforms detected 
by the MAb 16A, specific for the B exon of CD45 (Bottomly 
et al., 1989). We had previously shown that these subsets 
differ in their activation requirements, with memory CD4 
T cells responding to anti-CD3 bound to plastic surfaces 
or cross-linked by Fc receptor-bearing fibroblasts, while 
naive CD4 T cells responded to anti-CD3 only in the pres- 
ence of APC from T-depleted spleen. These earlier studies 
suggested that the activation requirements of naive CD4 
T cells are more stringent than those of memory CD4 T 
cells (Luqman and Bottomly, 1992). This is consistent with 
results demonstrating that human memory cells (CD45RO+) 
obtained from peripheral blood were more easily activated 
and more sensitive to stimulation through TCR/CD3 than 
naive cells (CD45RA+) (Byrne et al., 1988; Horgan et al., 
1990; Sanders et al., 1989). 
However, in the present studies we noted the anomaly 
that memory CD4 T cells failed to respond to anti-CD3 
presented by MHC class II+ APC, whereas naive CD4 T 
cells were fully responsive to this stimulus. Although this 
result appeared paradoxical, other studies have demon- 
strated that memory CD4 T cells are less responsive than 
their naive counterparts to noncognate stimuli (Lee and 
Vitetta, 1992; Jenkins and Miller 1992). For example, when 
stimulated with staphylococcal enterotoxin B and APC, 
CD45RBb memory CD4 T cells failed to proliferate, whereas 
CD45RBh’ cells proliferated well (Lee and Vitetta, 1992). 
CD4 T cell activation by anti-CD3 added in soluble form 
requires presentation by an FcR-expressing accessory 
cell. The present studies show that MHC class II molecules 
on FcR-bearing cells inhibit anti-CD3-induced proliferation 
and effector cytokine secretion by memory but not by naive 
CD4 T cells. This was established using MHC class II+ 
and class II- FcyR+ transfectants as well as T-depleted 
spleen cells from MHC class II-deficient mice. The likely 
target of the MHC class II molecules on CD4 T cells is 
CD4 itself (Doyle and Strominger, 1987) the only protein 
known to bind specifically to MHC class II, and indeed, 
ligation of CD4 by anti-CD4 antibody could fully reproduce 
the selective inhibition of memory but not naive CD4 T 
cells seen with anti-CD3 and MHC class II+ APC. Previous 
studies with unseparated CD4 T cells demonstrating that 
CD4 cross-linking did not inhibit responses to anti-CD3 
and APC (Newell et al., 1990) are not inconsistant with 
our results, because the inhibition of memory cells was 
likely masked by the lack of inhibition of naive cells. 
There are several possible implications of our finding 
that CD4 ligation by MHC class II molecules inhibits stimu- 
lation of memory, but not naive, CD4 T cells. To begin 
with, such signals that inhibit cytokine release by memory 
or effector CD4 T cells may be important in limiting by- 
stander effects. For example, as a memory CD4 T cell 
trafficks through lymph nodes, it will encounter many MHC 
class II-bearing cells that do not express its specific li- 
gand, and some that do. Those that express specific anti- 
gen-MHC will activate the cell, causing it to secrete cyto- 
kines. A negative signal, which shuts off effector cytokine 
production, may be important in preventing these CD4 T 
cells from inappropriately activating adjacent B cells or 
macrophages that do not express antigen. Because mem- 
ory CD4 T cells express higher levels of adhesion mole- 
cules than do naive cells (Gray, 1993), facilitating their 
interaction with APC, such selective negative signalsdeliv- 
ered in the absence of antigen may also be necessary to 
prevent the persistence of irrelevant interactions between 
memory CD4 T cells and APC. This hypothesis (Tite et 
al., 1986) is supported by previous studies (Mazerolles et 
al., 1990) suggesting that antigen independent CD4-MHC 
class II interactions may promote CD4 T cell-APC separa- 
tion. Moreover, we propose that activation by the appro- 
priate MHC class II-peptide complex predominates over 
the inhibitory signal delivered by inappropriate contact 
with MHC class II-bearing APC, because MHC class II+ 
APCs were unable to inhibit activation of CD45RB” cells 
by either FcR+ MHC class II0 APCor immobilized antiCD3. 
The finding of selective inhibition of memory cells via 
CD4 also has implications to the immune dysfunctions 
observed in AIDS. Memory CD4 T cell function is the first 
defect observable in HIV infection (Helbert et al., 1993) 
and it has been demonstrated that cross-linking of CD4 
by gp120 causes apoptosis of T cells subsequently acti- 
vated by TCR cross-linking with anti-CD3 (Moebius et al., 
1992; Banda et al., 1992). Because memory CD4 T cells 
are shown here to be more susceptible than naive cells 
to negative signaling through CD4, it is intriguing to specu- 
late that they may likewise be more susceptible to gp120- 
mediated apoptosis or inactivation. 
Our results that memory CD4Tcells are selectively inac- 
tivated by MHC class II expression on APC appear in oppo- 
sition to the fact that CD45RBb or memory cells respond 
well to antigen (Bottomly et al., 1989). We believe that 
the apparent discrepancy lies in the activating stimulus 
employed in these studies, anti-CD3 cross-linked by FcR 
bearing APC. Whereas antigen presented as peptides by 
MHC class II molecules forms a ligand that binds to both 
CD4 and the TCR promoting the physical association of 
these two molecules, which facilitates activation, stimula- 
tion by anti-CD3 involves a TCR/CD3-FcR interaction, 
which should not promote the TCR-CD4 interaction. Fur- 
thermore, we have observed that antiCD3, and antiCD3- 
Fab can dissociate TCR and CD4 on memory CD4 T cells 
and cloned T cell lines (J. Rojo, U. Dianzani, M. L., C. 
Janeway, and K. B., unpublished data). These data sug- 
gest that in contrast with antigen, anti-CD3 sterically inhib- 
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its the association of CD4 with the TCR. Finally, it has 
been shown (Dianzani et al, 1992) that IgM antiCD4, 
which efficiently cross-links CD4, potently inhibits activa- 
tion of a cloned CD4 T cell line by anti-TCR and anti-CD3 
antibodies, but has little or no effect on the response of 
these same T cells to antigen. Thus, our experimental 
system has to be viewed as revealing inhibitory signals 
that are induced by cross-linking CD4 distinct from the 
TCR, which, we propose, constrain the activity of memory 
CD4 T cells but do not impede the proper functioning of 
these cells when they encounter specific antigen-MHC 
class II complexes on APC. 
The selective susceptibility of memory CD4 T cells to 
negative signaling through CD4 and differential activation 
through CD3 strongly implies that both CD3 and CD4 are 
coupled to different biochemical signaling events in mem- 
ory and naive T cells. We have shown here that following 
both CD3 and CD4 cross-linking, strikingly dissimilar pat- 
terns of tyrosine-phosphorylated proteins appear in the 
two CD45RB subsets. The pattern of tyrosine-phosphory- 
lated proteins seen in CD45RBhi parallels that seen with 
whole CD4 cells, indicating that the selecting antibody 
used to isolate the cells did not qualitatively affect signal- 
ing. There are more major tyrosine-phosphorylated pro- 
teins after CD3 cross-linking in naive cells than in memory 
cells, including major 70-80 kDa bands that are present 
exclusively in naive cells and may contain the ZAP-70 ki- 
nase that has been shown to be phosphorylated and acti- 
vated immediately following TCR/CD3 stimulation (Chan 
et al, 1991). These datasuggest that different kinases may 
be activated through TCRED3 in naive versus memory 
T cells and identification of those kinases may provide the 
key to determining the molecular basis of differential T 
cell activation. Although it has been shown in Tcells clones 
that the p58kk kinase can tranduce negative signals through 
CD4 (Haughn, et al., 1992) we have found no differences 
in CDCassociated and total p581Ck kinase activity between 
the two subsets by immunoprecipitation and in vitro kinase 
assay (data not shown), suggesting the involvement of 
other kinases in differential tyrosine phosphorylation after 
CD3 and CD4 ligation, and in preferential CD4-mediated 
negative signaling of CD45RB’O cells. 
It has recently been demonstrated in our laboratory that 
CD45 isoforms can influence activation through the TCR 
in CD45 isoform transfectants (Novak et al, 1994). We 
have previously shown by cocapping analysis that CD45 
isoforms also modulate associations with CD4 and TCRl 
CD3, with the CD45 isoforms expressed by memory 
(CD45RB’O) cells preferentially associating with CD4 and 
TCRICD3 and the CD45 isoforms expressed by naive 
(CD45RBhi) cells not associating with CD4 or TCR/CD3 
(Dianzani et al, 1990). The physical context of TCR, CD4, 
and CD45 on CD45RB’O and CD45RBhi cell surfaces may 
thus direct the differential activation of both TCR- and CD4- 
associated tyrosine kinases, leading to the appearance 
of distinct species of tyrosine-phosphorylated substrates 
when CD4 or CD3 are cross-linked in the two subsets. 
Further evidence that CD45 isoform expression may gov- 
ern the differential activation and CDCmediated negative 
signaling observed in this study is suggested in studies 
using CD45 isoform transgenic mice. Thymocytes (nor- 
mally CD45RB’O) expressing a CD45ABC transgene (ren- 
dering them CD45RBh’) became resistant to anti-CD4 
mediated negative signaling (Chui et al, 1994), consistent 
with our results with peripheral CD45RBhi cells. Interest- 
ingly, CD45RBhi thymocytes from these ABC transgenic 
mice also exhibited major 70 and 80 kDa bands after anti- 
CD3 stimulation that were not present in stimulated 
CD45RB” thymocytes from null isoform transgenic mice 
(Chui et al., 1994), suggesting a biochemical correlation 
between CD45RBhi isoform expression and the appear- 
ance of 70 kDa, 80 kDa, or both tyrosine-phosphorylated 
bands after activation. 
In conclusion, our studies reveal that the function of CD4 
expressed by memory T cells differs from that observed 
with naive T cells. The inhibitory actions are particularly 
important in CD4 T cells that express low molecular mass 
isoforms of CD45, perhaps because these associate phys- 
ically with CD4 and modulate its activity. We also present 
here clear differences in signaling through CD3 and CD4 
in the two CD4 subsets. Our findings have important impli- 
cations for regulation of CD4 T cell effector function and 
for the defective action of memory CD4 T cells seen as the 
earliest effect of infection with HIV. Further biochemical 
characterization of intracellular events occurring in these 
two subsets following CD3 ligation, CD4 ligation, or both 
will enable us to determine the molecular mechanisms 
underlying the complex regulation of naive and memory 
CD4 T cell activation. 
Experimental Procedures 
Mice 
Female BALB/c ByJ mice were obtained from the Jackson Laboratory 
(Bar Harbor, Maine) and were maintained at the animal facility at Yale 
University (New Haven, Connecticut). All mice were used between 
6-12 weeksofage. Class II knockout mice (RHABo/o) originally derived 
from 129/Sv mice (Cosgrove et al.. 1991) were provided by Dr. D. 
Mathis (Institut de Chimie Biologique, Strasbourg, France) and were 
bred and maintained at Yale University. 
Antlbodies 
Unless otherwise indicated, all MAbs used were purified from superna- 
tants from hybridomas maintained in this laboratory, using standard 
protein A or protein G affinity chromatography. The following MAbs 
were used in this study: C363.16A (rat IgG2a, antiCD45AB)(Bottomly 
et al., 1989); C363.298 (rat IgGPc, antiCD3s) (Portoles et al., 1989); 
MEL-14 (rat IgGPa, anti-lymphocyte homing receptor) (Gallatin et al., 
1983); IM7.8.1 (rat IgG2b, anti-pap-l) (Trowbridgeet al., 1982); 2.4.G2 
(rat IgGPb, anti-muFcyRII) (Unkeless, 1979); GKl.5 (rat IgGPb, anti- 
CD4) (Dialynas et al., 1983); anti-CD8 (rat IgG2a, clone 53-6.72) (Led- 
betterandHerzenberg. 1979);antiCDE(rat IgGPb,clone2.43),212.A1 
(mouse IgGPa, anti-l-Ad) (Landais et al., 1987); MKD6 (mouse IgGPa, 
anti-l-Ad) (Kappler et al., 1981); 11811 (anti-lL-4) (Ohara and Paul, 
1955); and XMGI .2 (anti-IFNy) (Cherwinski et al., 1987). 
Cell Lines and Transfectlons 
The murine L cell lines DAP.3 and 4404.87, an I-Ad-expressing DAP.3 
cell (Konig et al., 1992) were provided by Dr. Ft. N. Germain (National 
Institutes of Health, Bethesda, Maryland). These cells were cotrans- 
fected with expression vectors containing the full-length muFcyFtllb2 
cDNA (Ravetch et al, 1986) constructed by cloning muFcyRllb2 cDNA 
(provided by Dr. I. Mellman, Yale University), into a modified pSP72 
vector containing the SRa promoter (Takebe et al., 1988) (unpublished 
construct provided by Dr. T. Novak, Yale University), along with 
pSMhyg, encoding a hygromycin B resistance gene. Cells were 
transfected as monolayers using Lipofectin (GIBCO BRL, Gaithers- 
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burg, Maryland) according to the protocol of the manufacturer. Stable 
transfectants, designated UFcFt*/IF and L/FcR+/ll+. were selected in 
DMEM, 5% fetal catf serum, 10 mM HEPES, 2 mM glutamine, 50 U/ml 
penicillin-streptomycin sulfate, 300-350 ug/ml hygromycin B (Calbio- 
them. La Jolla, California) and 250 &ml G416 for UFcR+/II+ cells. 
Resistant colonies were expanded and sorted twice for FcyRll expres- 
sion on the FACStar (Becton-Dickinson, Mountain View, California) 
based on 2.462 staining. 
Prepnratlon of CD4 T Cells and Separation 
Into CD45RB Bubseta 
CD4 T cells were isolated by immunomagnetic sefection from BALB/c 
splenocytes as described previously (Luqman and Bottomly, 1992). 
In brief, splenic CD4 T cells were isolated by negative selection using 
MAbs to CD6, and to class II, followed by incubation with anti-rat IgG-, 
anti-mouse IgG-. and anti-mouse IgM-coated magnetic beads (Collab- 
orative Research, Bedford, Massachusetts); CD4 cells were collected 
by magnetic depletion and centrifuged through a 62%-65% percoll 
gradient to remove activated T cells and contaminating accessory 
cells. The resultant CD4 population, as assessed by staining with 
GK1.5, was 65%-90% pure. Separation of CD4 cells into CD45RB” 
and CD45RB”’ subsets, was carried out by MACS separation (Miltenyi 
et al., 1990) according to the protocol of the manufacturer (Miltenyi 
Biotec, Sunnyvale, California), with some modifications. In brief, CD4 
T cells were incubated for 20 min on ice with C363.16A-biotin (anti- 
CD45RB), followed by incubation with strepavidin magnetic beads (Mi- 
tenyi Biotec, Sunnyvale, California). The stained CD4+ T cells were 
applied to a MACS separation column fitted between a superMACS 
magnet. Nonadherent CD45RBb cells were collected first, columns 
were washed extensively, and bound CD45RB”’ cells were eluted out- 
side the magnetic field and reapplied to the magnetic column two to 
three times to ensure thorough separation of CD45RB” and CD45RB”’ 
subsets. Purity of each population was assessed by staining with fluo- 
rescein isothiocyanate-avidin D (Vector Laboratories, Burlingame, 
California). The resultant CD45RB’” population was >95% CD4, and 
the CD45RBh’ subset was 65%-900/b CD4, as determined by GKl.5 
staining. 
Preparation of APCs 
Splenic APCs were prepared by complement depletion of BALB/c or 
RHAf3o/o splenocytes treated with anti-Thyl, antiCD4, and anti-CD6 
antibodies. Following complement depletion, cells were treated with 
50 pg/ml mitomycin C (Boehringer Mannheim Biochemica, Federal 
Republic of Germany) as described previously (Luqman and Bottomly, 
1992). Purity of the APC preparation was assessed by anti-class II 
staining for BALB/c, and anti-FcRII (2.4G2) staining for MHC class IF 
APC. Purity was >95% MHC class II+ and/or FcRII’cells in both cases. 
In experiments where fibroblasts were used as APC. transfected fibro- 
blasts were fixed in 1% paraformaldehyde at 3 x 1 O8 cells/ml for 25 
min at 25OC. Following extensive washing with phosphate-buffered 
saline, fixed cells were resuspended in media and incubated 4-6 hr 
at 37OC before using in assays. 
Prollferfdlon Assays 
CD45RBb and CD45RB”’ CD4 T cells were cultured at 25,000 cells/ 
well in 96well flat-bottomed plates (Costar, Cambridge, Massachu- 
setts) with soluble anti-CD3 in the presence or absence of antiCD4, 
anti-FcR, or Notype-matched control antibodies at indicated concen- 
trations and 75,000 splenic APCs/well or 50,000 fixed fibroblastslwell 
in Eagles high amino acid medium (Peck and Bach, 1973) supple- 
mented with 5% fetal calf serum, 50 U/ml penicillin, 50 &t/ml strepto- 
mycin sulfate, and 10 mM HEPES. To immobilize antibody on plates, 
anti-CD3 was diluted to indicated concentrations in 50 mM Tris-HCI 
(pH 9.5) and incubated 2-4 hr at 37OC. Wells were washed with me- 
dium twice before culturing 25,000 T cells/well. Cultures were pulsed 
after 4 days with 1 uCi PH]dTdR (6.7 Cilmmol) per well and harvested 
16-24 hr later on a Tomtec 96well plate harvester. Radioactivity was 
quantitated by scintillation counting. Results are presented as aver- 
ages of triplicates and standard errors were <20% unless otherwise 
indicated. 
Cytoklne Assays 
IL-4 and IFNy in supernatants were measured by bioassay. For IL-4 
measurement, serial dilutions of supernatant from cultures described 
above were incubated were added to 10.000 CT.4S indicator cells 
(Hu-Li et al., 1969) in the presence or absence of anti-IL-4 antibody. 
Cultures were pulsed after 46 hr with 1 uCi PH]dTdR and harvested 
16-24 hr later. Standard plates were set up with serial titrations of 
recombinant mouse lL4(Becton-Dickinson, Bedford, Massachusetts) 
and units were calculated from standard curves with 1 U being defined 
as the amount of IL4 that gave half-maximal proliferation. In all assays, 
CT.4S proliferation was completely inhibited with anti-lL4. For nuanti- 
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tation of IFNy, dilutions of supernatant were incubated with 5000 
WEHI- cells (Warner et al., 1979) in the presence or absence of 
anti-IFNy antibody. Proliferation was assessed after 46 hr, with 1 U 
of IFNT defined as the concentration that gave half-maximal inhibition 
of WEHI- proliferation calculated from the standard curve obtained 
with mouse IFNy standard (Genzyme Corporation, Cambridge, Massa- 
chusetts). In all assays, inhibition of proliferation was blocked by 
anti-IFNy. 
Phosphotyroslne lmmunoblots 
CD4, CD45RB”. and CD45RB”‘cells were isolated as described above 
and incubated in media overnight at 37OC. This step was necessary 
to eliminate the high backround of tyrosine-phophorylated proteins 
that occurs after prolonged incubation at 4OC (data not shown). 
CD45RB” and CD45RB”‘cells were resuspended in RPM1 without fetal 
calf serum at 3 x 10’ cells/ml. For CD3 cross-linking, 1.5 x IO” cells 
in 50 ul RPM1 were incubated for 15 min on ice with C363.298 antibody, 
cells were pelleted and resuspended in 50 ul RPMI, and then 2 pg goat 
anti-rat F(ab’hwereaddedandcells wereplacedforvaryingamountsof 
time at 37OC. For CD4 cross-linking, RL172.5 (IgM antiCD4) was 
added to cells on ice, and incubated for 30 s to 2 min at 37OC. Cells 
were lysed in lysis buffer (20 mM Tris-HCI [pH 7.51, 150 mM NaCI, 1 
mM Mg&, 1 mM EGTA, containing 10 pg/ml leupeptin, 10 &ml 
aprotinin, 1 mM Pefabloc-sc, 50 mM NaF, 10 mM sodium pyrophos- 
phate, 1 mM sodium orthovanadate), kept on ice for 30 min. and centri- 
fuged at 13,000 rpm at 4OC to remove nuclear material. Proteins in 
the lysates were resolved on 5%-l 5% SDS gradient gels, transferred 
electrophoretically to nitrocellulose, and hybridized to anti-phosphoty 
rosineantibody4GlO(Upstate Biotechnology Associates, Lake Placid, 
New York) followed by horseradish peroxidase-coupled goat anti- 
mouse IgG (Biorad, Hercules, California). Bands were revealed by 
chemiluminescenceusingtheenhancedchemiluminescenceWestern 
blotting detection reagents (Amersham) according to the protocol of 
the manufacturer. 
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